Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
aminocaproic acid (amicar) (1964 NDA)
aluminum hydroxide (Gaviscon) (3 trials)
as03 (2 trials)
bnt162b2 (Comirnaty) (1 trial)
coronavac (1 trial)
cpg 1018 (2 trials)
hepatitis a vaccine, inactivated (vaqta) (1 trial)
scb-2019 (9 trials)
scb-2023 (1 trial)
vaxzevria (1 trial)
scb-2020s (2 trials)
aflibercept (zaltrap) (1 trial)
mitotane (lysodren) (2 trials)
scb-420 (1 trial)
Hemorrhage
Neoplasms (Phase 1)
Pleural Effusion (Phase 1)
Pleural Effusion, Malignant (Phase 1)
Trials (13 total)
Trial APIs (13 total)